The NeurologyLive® epilepsy clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to epilepsy and related epileptic conditions, including Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex, focal seizures, nonmotor seizures, and more.
Check out some of NeurologyLive®'s featured content in the carousel below.
Overlap Observed Between Perceived Stress, Felt Stigma, and Depressive Symptoms in Epilepsy
August 11th 2022When each variable was entered into the first step of hierarchical linear regression analysis, perceived stress explained more than 40% of the variance in depressive symptoms, followed by felt stigma, at about 20%.
Seizure-Related Injuries High in Epilepsy, Show Potential Quality of Life Strains
August 11th 2022People with epilepsy were less involved than controls in activities considered risky, such as driving and doing household chores, which may have suggested reduced social independence and legal limitations for driving.
Delayed Diagnosis of Functional Seizures Associated With Abnormal Processing of Face Emotions
August 9th 2022Increased posterior cingulate cortex activation to sad faces in the long-delay diagnostic group were associated with worse symptoms of depression, as expressed by Beck Depression Inventory scores.
Ganaxolone Now Available After Winning Landmark Approval for CDKL5 Deficiency Disorder
July 28th 2022The oral suspension, marked as Ztalmy by developer Marinus, is the first drug approval for cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (also known as CDD), given the greenlight in March. The agent is now available as of July 28, 2022.